ZHU:CA:TSX-BMO Equal Weight US Health Care (CAD)

COMMON STOCK | |

Last Closing

CAD 42.65

Change

0.00 (0.00)%

Market Cap

CAD 0.05B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-01 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
TD-PFB:CA Toronto Dominion Bank Pref B

N/A

CAD 201.44B
TD-PFD:CA Toronto Dominion Bank Pref D

-0.15 (-0.62%)

CAD 171.32B
TD-PFI:CA Toronto-Dominion Bank Pref Ser..

+0.26 (+1.02%)

CAD 161.26B
TD-PFM:CA Toronto-Dominion Bank Pref Ser..

N/A

CAD 143.36B
ENB-PFA:CA Enbridge Inc Pref 9

N/A

CAD 110.83B
ENB-PFV:CA Enbridge Inc Pref 5

+0.08 (+0.37%)

CAD 110.58B
ENB-PFC:CA Enbridge Inc Pref 11

+0.10 (+0.57%)

CAD 105.51B
ENB-PFG:CA Enbridge Inc Pref 15

N/A

CAD 102.21B
ENB-PFU:CA Enbridge Inc Pref L

+0.12 (+0.58%)

CAD 80.78B
PPL-PFA:CA Pembina Pipeline Corp Pref Ser..

+0.15 (+0.66%)

CAD 9.12B

ETFs Containing ZHU:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.15% N/A N/A 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.15% N/A N/A 41% F
Trailing 12 Months  
Capital Gain 2.80% N/A N/A 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.80% N/A N/A 29% F
Trailing 5 Years  
Capital Gain 37.89% N/A N/A 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.89% N/A N/A 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 6.67% N/A N/A 64% D
Dividend Return 6.67% N/A N/A 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.97% N/A N/A 61% D-
Risk Adjusted Return 51.43% N/A N/A 74% C
Market Capitalization 0.05B N/A N/A 27% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike